Implanet S.A. (EPA:ALIMP)

Market Cap	21.37M
Revenue (ttm)	9.41M
Net Income (ttm)	-4.37M
Shares Out	124.97M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	204,139
Average Volume	871,139
Open	0.1750
Previous Close	0.1750
Day's Range	0.1685 - 0.1830
52-Week Range	0.0800 - 0.2340
Beta	0.87
RSI	58.55
Earnings Date	Sep 16, 2025

About Implanet

Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. Implanet S.A.was founded in 2006 and is based in Martill...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 46
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIMP

Financial Performance

In 2024, Implanet's revenue was 9.41 million, an increase of 26.31% compared to the previous year's 7.45 million. Losses were -4.37 million, -34.60% less than in 2023.